AKT1 and breast carcinoma: Consistent with our findings that PRL2 increases miR-21 expression in breast cancer cells (Figure 2A,B), overexpression of PRL2 markedly down-regulated PTEN and increased AKT phosphorylation in both M231 and MCF7 cells (Figure 5A,B).